CGAS and mastitis: Using a combined pharmacological and genetic approach, we confirmed the pathway's necessity: the cGAS inhibitor RU.521 significantly reduced mEVs-induced inflammation, and STING −/− mice were largely protected from mEVs-triggered mastitis.